Accuray Incorporated (ARAY)
USD 1.79
(-6.28%)
USD 1.79
(-6.28%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 446.55 Million USD | -0.24% |
| 2023 | 447.6 Million USD | 4.12% |
| 2022 | 429.9 Million USD | 8.48% |
| 2021 | 396.28 Million USD | 3.49% |
| 2020 | 382.92 Million USD | -8.56% |
| 2019 | 418.78 Million USD | 3.43% |
| 2018 | 404.89 Million USD | 5.6% |
| 2017 | 383.41 Million USD | -3.86% |
| 2016 | 398.8 Million USD | 5.0% |
| 2015 | 379.8 Million USD | 2.81% |
| 2014 | 369.41 Million USD | 16.91% |
| 2013 | 315.97 Million USD | -22.79% |
| 2012 | 409.22 Million USD | 84.1% |
| 2011 | 222.28 Million USD | 0.3% |
| 2010 | 221.62 Million USD | -5.13% |
| 2009 | 233.59 Million USD | 11.04% |
| 2008 | 210.38 Million USD | 49.79% |
| 2007 | 140.45 Million USD | 165.52% |
| 2006 | 52.89 Million USD | 136.39% |
| 2005 | 22.37 Million USD | 14.35% |
| 2004 | 19.56 Million USD | 622.1% |
| 2003 | 2.71 Million USD | -86.0% |
| 2002 | 19.35 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 134.28 Million USD | 32.79% |
| 2024 FY | 446.55 Million USD | -0.24% |
| 2024 Q1 | 103.89 Million USD | -12.17% |
| 2024 Q2 | 107.23 Million USD | 3.22% |
| 2024 Q3 | 101.13 Million USD | -5.69% |
| 2023 Q1 | 96.49 Million USD | -12.3% |
| 2023 Q4 | 118.29 Million USD | 0.2% |
| 2023 Q3 | 118.06 Million USD | 2.88% |
| 2023 Q2 | 114.76 Million USD | 18.93% |
| 2023 FY | 447.6 Million USD | 4.12% |
| 2022 Q4 | 110.02 Million USD | 14.41% |
| 2022 Q3 | 96.16 Million USD | -17.29% |
| 2022 FY | 429.9 Million USD | 8.48% |
| 2022 Q1 | 107.44 Million USD | -3.15% |
| 2022 Q2 | 116.27 Million USD | 8.22% |
| 2021 Q4 | 110.93 Million USD | 8.16% |
| 2021 Q1 | 85.33 Million USD | -10.16% |
| 2021 FY | 396.28 Million USD | 3.49% |
| 2021 Q2 | 97.45 Million USD | 14.21% |
| 2021 Q3 | 102.56 Million USD | 5.24% |
| 2020 Q1 | 89.57 Million USD | -23.71% |
| 2020 Q2 | 98.82 Million USD | 10.33% |
| 2020 Q3 | 99.54 Million USD | 0.73% |
| 2020 Q4 | 94.97 Million USD | -4.59% |
| 2020 FY | 382.92 Million USD | -8.56% |
| 2019 Q4 | 117.41 Million USD | 13.75% |
| 2019 FY | 418.78 Million USD | 3.43% |
| 2019 Q1 | 95.82 Million USD | -15.78% |
| 2019 Q2 | 102.31 Million USD | 6.77% |
| 2019 Q3 | 103.22 Million USD | 0.88% |
| 2018 Q1 | 90.95 Million USD | -18.86% |
| 2018 Q2 | 100.32 Million USD | 10.31% |
| 2018 FY | 404.89 Million USD | 5.6% |
| 2018 Q3 | 99.83 Million USD | -0.5% |
| 2018 Q4 | 113.78 Million USD | 13.98% |
| 2017 FY | 383.41 Million USD | -3.86% |
| 2017 Q4 | 112.09 Million USD | 15.19% |
| 2017 Q3 | 97.31 Million USD | 11.21% |
| 2017 Q1 | 86.5 Million USD | -8.92% |
| 2017 Q2 | 87.5 Million USD | 1.15% |
| 2016 Q2 | 108.91 Million USD | 21.51% |
| 2016 Q1 | 89.63 Million USD | -11.91% |
| 2016 Q3 | 105.28 Million USD | -3.33% |
| 2016 Q4 | 94.97 Million USD | -9.79% |
| 2016 FY | 398.8 Million USD | 5.0% |
| 2015 Q2 | 98.15 Million USD | 19.15% |
| 2015 FY | 379.8 Million USD | 2.81% |
| 2015 Q4 | 101.75 Million USD | 4.34% |
| 2015 Q3 | 97.51 Million USD | -0.65% |
| 2015 Q1 | 82.38 Million USD | -19.23% |
| 2014 Q3 | 97.14 Million USD | 3.75% |
| 2014 Q1 | 76.64 Million USD | -9.73% |
| 2014 Q2 | 93.63 Million USD | 22.17% |
| 2014 Q4 | 102 Million USD | 5.0% |
| 2014 FY | 369.41 Million USD | 16.91% |
| 2013 Q4 | 84.9 Million USD | 20.35% |
| 2013 Q1 | 82.74 Million USD | -17.69% |
| 2013 Q3 | 70.54 Million USD | -9.3% |
| 2013 Q2 | 77.77 Million USD | -6.0% |
| 2013 FY | 315.97 Million USD | -22.79% |
| 2012 FY | 409.22 Million USD | 84.1% |
| 2012 Q4 | 100.53 Million USD | -1.26% |
| 2012 Q1 | 100.45 Million USD | 33.54% |
| 2012 Q2 | 106.42 Million USD | 5.95% |
| 2012 Q3 | 101.81 Million USD | -4.33% |
| 2011 Q4 | 75.22 Million USD | 37.4% |
| 2011 Q3 | 54.74 Million USD | 0.92% |
| 2011 Q2 | 54.24 Million USD | 42.5% |
| 2011 Q1 | 38.06 Million USD | -38.39% |
| 2011 FY | 222.28 Million USD | 0.3% |
| 2010 Q4 | 61.78 Million USD | 18.96% |
| 2010 Q3 | 51.94 Million USD | -9.39% |
| 2010 Q2 | 57.32 Million USD | 13.34% |
| 2010 Q1 | 50.57 Million USD | -13.99% |
| 2010 FY | 221.62 Million USD | -5.13% |
| 2009 Q4 | 58.8 Million USD | -4.07% |
| 2009 Q2 | 57.63 Million USD | 3.19% |
| 2009 Q1 | 55.85 Million USD | 9.65% |
| 2009 FY | 233.59 Million USD | 11.04% |
| 2009 Q3 | 61.3 Million USD | 6.36% |
| 2008 Q4 | 50.93 Million USD | -13.31% |
| 2008 Q2 | 52.03 Million USD | 6.97% |
| 2008 FY | 210.38 Million USD | 49.79% |
| 2008 Q1 | 48.64 Million USD | 10.57% |
| 2008 Q3 | 58.75 Million USD | 12.91% |
| 2007 FY | 140.45 Million USD | 165.52% |
| 2007 Q1 | 32.77 Million USD | 100.53% |
| 2007 Q2 | 26.34 Million USD | -19.6% |
| 2007 Q3 | 37.34 Million USD | 41.72% |
| 2007 Q4 | 43.99 Million USD | 17.82% |
| 2006 Q3 | 16.34 Million USD | 0.0% |
| 2006 Q1 | 3.87 Million USD | -30.8% |
| 2006 FY | 52.89 Million USD | 136.39% |
| 2006 Q2 | 16.34 Million USD | 322.16% |
| 2006 Q4 | 16.34 Million USD | 0.0% |
| 2005 Q1 | 5.59 Million USD | 0.0% |
| 2005 Q3 | 5.59 Million USD | 0.0% |
| 2005 Q2 | 5.59 Million USD | 0.0% |
| 2005 Q4 | 5.59 Million USD | 0.0% |
| 2005 FY | 22.37 Million USD | 14.35% |
| 2004 FY | 19.56 Million USD | 622.1% |
| 2003 FY | 2.71 Million USD | -86.0% |
| 2002 FY | 19.35 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Envoy Medical, Inc. | 316 Thousand USD | -141213.608% |
| Delcath Systems, Inc. | 2.06 Million USD | -21524.746% |
| Xylo Technologies Ltd. | 91.72 Million USD | -386.842% |